Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment ; volume:6 ; number:1 ; day:26 ; month:3 ; year:2006 ; pages:1-7 ; date:12.2006
BMC cancer ; 6, Heft 1 (26.3.2006), 1-7, 12.2006
- Creator
-
Bartsch, Rupert
- Contributor
-
Wenzel, Catharina
Pluschnig, Ursula
Hussian, Dagmar
Sevelda, Ursula
Altorjai, Gabriela
Locker, Gottfried J.
Mader, Robert
Zielinski, Christoph C.
Steger, Guenther G.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-6-81
- URN
-
urn:nbn:de:1111-2016030341477
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bartsch, Rupert
- Wenzel, Catharina
- Pluschnig, Ursula
- Hussian, Dagmar
- Sevelda, Ursula
- Altorjai, Gabriela
- Locker, Gottfried J.
- Mader, Robert
- Zielinski, Christoph C.
- Steger, Guenther G.
- SpringerLink (Online service)
Other Objects (12)
Improved tumour marker sensitivity in detecting colorectal liver metastases by combined type IV collagen and CEA measurement
Enolase Isoenzymes as Tumour Markers
Limited Improvement of Tumour Diagnosis by the Simultaneous Determination of Carcinoembryonic Antigen (CEA) and of a Tumour-Associated CEA-Related Antigen of Mr 128000 in Serum
Lymphocyte predominance in blood, pleural fluid, and tumour stroma; a prognostic marker in pleural mesothelioma
Biomarkers in cancer/Circulating tumour markers
Clinical use of the tumor marker system CEA - TPA
CEA und CA 15-3 als Prognosefaktoren beim Mammakarzinom
Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients
CEA
S47. Tumour infiltrating lymphocytes - a predictive marker?
Die Tumormarker CEA und CA 15-3 beim metastasierenden Mammakarzinom
Raised CA19–9 and CEA have prognostic relevance in gallbladder carcinoma
Improved tumour marker sensitivity in detecting colorectal liver metastases by combined type IV collagen and CEA measurement
Enolase Isoenzymes as Tumour Markers
Limited Improvement of Tumour Diagnosis by the Simultaneous Determination of Carcinoembryonic Antigen (CEA) and of a Tumour-Associated CEA-Related Antigen of Mr 128000 in Serum
Lymphocyte predominance in blood, pleural fluid, and tumour stroma; a prognostic marker in pleural mesothelioma
Biomarkers in cancer/Circulating tumour markers
Clinical use of the tumor marker system CEA - TPA
CEA und CA 15-3 als Prognosefaktoren beim Mammakarzinom
Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients
CEA
S47. Tumour infiltrating lymphocytes - a predictive marker?
Die Tumormarker CEA und CA 15-3 beim metastasierenden Mammakarzinom
Raised CA19–9 and CEA have prognostic relevance in gallbladder carcinoma
Improved tumour marker sensitivity in detecting colorectal liver metastases by combined type IV collagen and CEA measurement
Enolase Isoenzymes as Tumour Markers
Limited Improvement of Tumour Diagnosis by the Simultaneous Determination of Carcinoembryonic Antigen (CEA) and of a Tumour-Associated CEA-Related Antigen of Mr 128000 in Serum
Lymphocyte predominance in blood, pleural fluid, and tumour stroma; a prognostic marker in pleural mesothelioma
Biomarkers in cancer/Circulating tumour markers
Clinical use of the tumor marker system CEA - TPA
CEA und CA 15-3 als Prognosefaktoren beim Mammakarzinom
Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients
CEA
S47. Tumour infiltrating lymphocytes - a predictive marker?
Die Tumormarker CEA und CA 15-3 beim metastasierenden Mammakarzinom